Page last updated: 2024-12-10

s-pentachlorobuta-1,3-dien-yl-cysteine

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

S-pentachlorobuta-1,3-dien-yl-cysteine: nephrotoxic; structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID3033729
MeSH IDM0117812

Synonyms (10)

Synonym
s-pentachlorobuta-1,3-dien-yl-cysteine
ccris 2171
l-cysteine, s-(1,2,3,4,4-pentachloro-1,3-butadienyl)-
s-(1,2,3,4,4-pentachloro-1,3-butadienyl)-l-cysteine
(2r)-2-amino-3-[(1e)-1,2,3,4,4-pentachlorobuta-1,3-dienyl]sulfanylpropanoic acid
5-(1,2,3,4,4-pentachloro-1,3-butadienyl)-l-cysteine
87619-82-7
s-pentachlorobutadienyl-l-cysteine
(s-pentachlorobutadienyl)-l-cysteine
s-(1,2,3,4,4-pentachloro-1,3- butadienyl)-l-cysteine

Research Excerpts

Toxicity

ExcerptReferenceRelevance
" Aminooxyacetic acid (AOAA), an inhibitor of cysteine conjugate beta-lyase, reduced the covalent binding of PCBC-equivalents to tubular protein by approximately 90% and decreased but did not prevent the toxic effects produced by PCBC on RPT respiration and cellular ATP levels."( Pentachlorobutadienyl-L-cysteine (PCBC) toxicity: the importance of mitochondrial dysfunction.
Groves, CE; Lock, EA; Schnellmann, RG; Sokol, PP; Steffens, TG, 1991
)
0.28
" DCVC was consistently found to be more toxic than DCVG, but the inclusion of gamma-glutamyltransferase (0."( Renal cysteine conjugate beta-lyase-mediated toxicity studied with primary cultures of human proximal tubular cells.
Chen, JC; Jones, TW; Stevens, JL; Trifillis, AL, 1990
)
0.28
" PCBC (20-500 microM) induced a specific sequence of toxic events."( A mechanism of S-(1,2,3,4,4-pentachloro-1,3-butadienyl)-L-cysteine toxicity to rabbit renal proximal tubules.
Lock, EA; Mandel, LJ; Schnellmann, RG, 1987
)
0.27
" HCBD was about four times more toxic to female rats than males."( Nephrotoxicity of hexachlorobutadiene and its glutathione-derived conjugates.
Ishmael, J; Lock, EA, 1986
)
0.27
" The mechanism of protection conferred to rats by an ADT pretreatment against HCBD-induced nephrotoxicity appears to take place in the kidney at a step beyond the generation of ultimate toxic metabolites derived from PCBC."( Assessment of the role of glutathione conjugation in the protection afforded by anethol dithiolthione against hexachloro-1,3-butadiene-induced nephrotoxicity.
Bouthillier, L; Brodeur, J; Charbonneau, M, 1996
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (18)

TimeframeStudies, This Drug (%)All Drugs %
pre-19907 (38.89)18.7374
1990's7 (38.89)18.2507
2000's1 (5.56)29.6817
2010's0 (0.00)24.3611
2020's3 (16.67)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 11.08

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index11.08 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.17 (4.65)
Search Engine Demand Index0.00 (26.88)
Search Engine Supply Index0.00 (0.95)

This Compound (11.08)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (4.76%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other20 (95.24%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]